Search Results - Jianmin Wang

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Mediastinal lymph node dissection versus mediastinal lymph node sampling for early stage non-small cell lung cancer: a systematic review and meta-analysis. by Xiongfeng Huang, Jianmin Wang, Qiao Chen, Jielin Jiang

    Published 2014-01-01

    <h4>Objective</h4>This systematic review and meta-analysis aimed to evaluate the overall survival, local recurrence, distant metastasis, and complications of mediastinal lymph node dissection (MLND) versus mediastinal lymph node sampling (MLNS) in stage I-IIIA non-small cell lung cancer...

    Full description

    Get full text
    Article
  2. 2

    Robustness of ecological indicators to species misidentification in the national forest inventory of the United States by Jonathan Knott, Jianmin Wang, David Walker, Grant Domke, Songlin Fei

    Published 2025-07-01

    Abstract Longitudinal data are essential to assessing change in environmental parameters over space and through time. This is particularly true in forest ecosystems where demographic patterns are controlled by many biotic and abiotic factors that may only be observed through repeated measures of tre...

    Full description

    Get full text
    Article
  3. 3

    Shared diagnostic genes and potential mechanisms between intervertebral disc degeneration and diabetes mellitus revealed by integrated transcriptomic analysis and machine learning by Bao Song, Jianmin Wang, Hao Tang, Huadong Li, Wanli Zhang

    Published 2025-07-01

    IntroductionIntervertebral disc degeneration (IDD) and diabetes mellitus (DM) are clinically associated beyond traditional risk factors, yet the shared molecular mechanisms remain unclear.MethodsWe integrated transcriptomic data from IDD and DM cohorts, performed differential expression and protein–...

    Full description

    Get full text
    Article
  4. 4

    Phosphatase and tensin homolog deleted on chromosome 10 degradation induced by NEDD4 promotes acquired erlotinib resistance in non–small-cell lung cancer by Huake Sun, Huiwen Ma, Jianmin Wang, Liqin Xia, Guangkuo Zhu, Zhoufei Wang, Jianguo Sun, Zhengtang Chen

    Published 2017-07-01

    Acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors, such as gefitinib and erlotinib, is a critical issue in the treatment of patients with epidermal growth factor receptor mutant–positive non–small-cell lung cancer. Recent evidence suggests that downregulation of gene...

    Full description

    Get full text
    Article
  5. 5

    Diffusion-based generative drug-like molecular editing with chemical natural language by Jianmin Wang, Peng Zhou, Zixu Wang, Wei Long, Yangyang Chen, Kyoung Tai No, Dongsheng Ouyang, Jiashun Mao, Xiangxiang Zeng

    Published 2025-06-01

    Recently, diffusion models have emerged as a promising paradigm for molecular design and optimization. However, most diffusion-based molecular generative models focus on modeling 2D graphs or 3D geometries, with limited research on molecular sequence diffusion models. The International Union of Pure...

    Full description

    Get full text
    Article
  6. 6

    Anticancer Quinolinol Small Molecules Target Multiple Pathways to Promote Cell Death and Eliminate Melanoma Cells Resistant to BRAF Inhibitors by Xinjiang Wang, Rati Lama, Alexis D. Kelleher, Erika C. Rizzo, Samuel L. Galster, Chao Xue, Yali Zhang, Jianmin Wang, Jun Qu, Sherry R. Chemler

    Published 2025-06-01

    Small molecule inhibitors that target the E3 ligase activity of MDM2-MDM4 have been explored to inhibit the oncogenic activity of MDM2-MDM4 complex. MMRi62 is a small molecule that was identified using an MDM2-MDM4 E3 ligase-based high throughput screen and a cell-death-based secondary screen. Our p...

    Full description

    Get full text
    Article
  7. 7

    Study on collateral sensitivity of tigecycline to colistin-resistant Enterobacter cloacae complex by Kaixin Yu, Jiming Wu, Mingjing Liao, Jianmin Wang, Chunli Wei, Wenzhang Long, Xuemei Gou, Yang Yang, Jin Wang, Xushan Liang, Chunjiang Li, Xiaoli Zhang

    Published 2025-07-01

    ABSTRACT The past decade has witnessed the emergence and spread of carbapenem-resistant Enterobacter cloacae complex (CRECC), presenting a significant clinical challenge and urgently demanding new treatment strategies against antimicrobial resistance (AMR). This study focused on the impact of tigecy...

    Full description

    Get full text
    Article
  8. 8

    Checkpoint immunotherapy is associated with preferential activation of tumor antigen–specific CD4+ T cells in MDS by Elizabeth A. Griffiths, Pragya Srivastava, Eduardo Cortes Gomez, Junko Matsuzaki, Kunle Odunsi, Laura W. Dillon, Devdeep Mukherjee, Christopher S. Hourigan, Jacqueline Peng, Shovik Bandyopadhyay, Kai Tan, Kristopher M. Attwood, Joseph B. Kuechle, Prashant K. Singh, Jianmin Wang, Michael J. Nemeth

    Published 2025-08-01

    Abstract: A growing body of literature suggests that the efficacy of DNA hypomethylating agents are mediated via activation of antitumor immune mechanisms. Based upon this hypothesis, early phase trials combining immune checkpoint inhibitors (ICIs) with azacitidine in patients with myelodysplastic s...

    Full description

    Get full text
    Article